145 related articles for article (PubMed ID: 8392247)
1. Anti-tumor immune response.
Hainaut P
Acta Clin Belg; 1993; 48(2):73-80. PubMed ID: 8392247
[No Abstract] [Full Text] [Related]
2. Clinical promise of tumour immunology.
Scott AM; Cebon J
Lancet; 1997 May; 349 Suppl 2():SII19-22. PubMed ID: 9164443
[No Abstract] [Full Text] [Related]
3. Cellular and humoral immune responses against cancer: implications for cancer vaccines.
Knuth A; Wölfel T; Meyer zum Büschenfelde KH
Curr Opin Immunol; 1991 Oct; 3(5):659-64. PubMed ID: 1755985
[TBL] [Abstract][Full Text] [Related]
4. Idiotypic interactions in immune responses to tumor-associated antigens.
Lee VK; Hellström KE; Nepom GT
Biochim Biophys Acta; 1986 Oct; 865(2):127-39. PubMed ID: 3533153
[No Abstract] [Full Text] [Related]
5. [Immunological problems in oncology (author's transl)].
Petruzzelli C; Comotti F; Pugnani M; Sacchi L; Cereser M
Ann Sclavo; 1979; 21(4):502-44. PubMed ID: 95475
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies against a 65-kDa tumor-associated phosphoprotein: development and use in cancer detection.
Wang S; Mirowski M; Sherman U; Walaszek Z; Hanausek M
Hybridoma; 1993 Apr; 12(2):167-76. PubMed ID: 8314597
[TBL] [Abstract][Full Text] [Related]
7. Immunotoxin therapy of malignancy.
Grossbard ML; Nadler LM
Important Adv Oncol; 1992; ():111-35. PubMed ID: 1582669
[No Abstract] [Full Text] [Related]
8. Anti-idiotypic tumor vaccines.
Hellström KE; Hellström I
Int Rev Immunol; 1989; 4(4):337-46. PubMed ID: 2519931
[No Abstract] [Full Text] [Related]
9. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
Schlom J; Weeks MO
Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
[No Abstract] [Full Text] [Related]
10. [NK cells--their role and importance in antitumor resistance].
Mircheva Zh
Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848
[No Abstract] [Full Text] [Related]
11. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
Jäger D; Jäger E; Bert F; Knuth A
Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
[No Abstract] [Full Text] [Related]
12. Monoclonal antibody-defined antigens on tumor cells.
Baldwin RW; Embleton MJ; Price MR
Biomembranes; 1983; 11():285-312. PubMed ID: 6338949
[No Abstract] [Full Text] [Related]
13. [Contemporary molecular-biological methods of cancer diagnosis and monitoring based on the humoral immune response to tumor-associated antigens].
Shebzukhov IuV; Belousov PV; Khlgatian SV; Sazykin AIu; Kuprash DV; Nedospasov SA
Mol Gen Mikrobiol Virusol; 2007; (2):3-6. PubMed ID: 17600920
[TBL] [Abstract][Full Text] [Related]
14. [Monoclonal antibodies as antineoplastic antibodies].
Hashimoto Y
Nihon Rinsho; 1983; 41(4):821-4. PubMed ID: 6887550
[No Abstract] [Full Text] [Related]
15. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
Rupniewska ZM; Adamczyk MB
Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
[No Abstract] [Full Text] [Related]
16. Cancer immunotherapy with autologous and allogeneic vaccines: a practical overview.
Shinitzky M; Skornick Y
Prog Clin Biol Res; 1990; 348():95-125. PubMed ID: 2201036
[No Abstract] [Full Text] [Related]
17. [Antigens and antigenic systems].
Cordón-Cardo C; Graus F
Med Clin (Barc); 1987 Mar; 88(9):381-7. PubMed ID: 3553765
[No Abstract] [Full Text] [Related]
18. Immune complexes in human malignant tumours. A review.
Segal-Eiras A; Croce MV
Allergol Immunopathol (Madr); 1984; 12(3):225-32. PubMed ID: 6382986
[TBL] [Abstract][Full Text] [Related]
19. Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture.
Schlom J
Cancer Res; 1986 Jul; 46(7):3225-38. PubMed ID: 3518915
[No Abstract] [Full Text] [Related]
20. Human monoclonal antibodies.
Kan-Mitchell J; Mitchell MS
Prog Clin Biol Res; 1989; 288():85-94. PubMed ID: 2717643
[No Abstract] [Full Text] [Related]
[Next] [New Search]
